Detected ·
Orakl Oncology
$34MSeries A
Orakl Oncology raised $34M in Series A, co-led by Norrsken VC and Singular, to advance its AI-driven platform predicting cancer drug responses using patient-derived tumour models.
- Website
- —
- linkedin.com/company/85957194
- Amount
- $34 000 000 USD
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-16 16:07:21 UTC
- Signal ID
- 7af2fafe-65ad-4760-8f6b-28ba2f7d9cef
As the API returns it
{
"id": "7af2fafe-65ad-4760-8f6b-28ba2f7d9cef",
"created_at": "2026-11-16T16:07:21.312048Z",
"company_name": "Orakl Oncology",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/85957194",
"event_type": "funding",
"funding_amount": 34000000,
"funding_currency": "USD",
"funding_stage": "series_a",
"message": "*Orakl Oncology raised $34M in Series A, co-led by Norrsken VC and Singular, to advance its AI-driven platform predicting cancer drug responses using patient-derived tumour models.*"
}